NASDAQ · Medical - Instruments & Supplies

QDEL (QDEL) Stock

$16.83 +4.86% NASDAQ: QDEL Healthcare

Valuation

MetricValue
Price$16.83
Market Cap$1.15B
P/E Ratio-0.65
P/B Ratio0.38
P/S Ratio0.28
EPS (TTM)$-16.69
52-Week High$35.58
52-Week Low$9.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-58.93%
ROA-19.62%
ROCE-47.86%
Gross Margin-33.66%
Operating Margin-33.66%
Net Margin-45.57%
Debt/Equity1.55
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.7B$3.3B$3.0B$2.8B$2.7B
Operating Profit$906.0M$844.0M$139.0M$-2.0B$-919.0M
Net Profit$704.0M$549.0M$-10.0M$-2.1B$-1.1B
EPS$16.43$9.56$-0.15$-30.54$-16.69
Op Margin53.3%25.8%4.6%-70.5%-33.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$8.9B$8.6B$6.4B$5.8B
Total Liabilities$501.0M$3.9B$3.6B$3.4B$3.8B
Cash$803.0M$293.0M$119.0M$98.0M$170.0M
Borrowings$139.0M$2.8B$2.6B$2.7B$2.8B

Latest News

3 Healthcare Stocks We Approach with Caution StockStory · Jul 22, 2026 QDEL: Lowering target price to $13.00 Argus Research · Jul 22, 2026 Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway Zacks · Jul 21, 2026 QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire · Jul 15, 2026 Spotting Winners: QuidelOrtho (NASDAQ:QDEL) And Healthcare Equipment and Supplies Stocks In Q1 StockStory · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$806.0M$885.0M$280.0M$83.0M$105.0M
Investing Cash Flow$-612.0M$-1.8B$-397.0M$-345.0M$-381.0M
Financing Cash Flow$-180.0M$-121.0M$-51.0M$-10.0M$-5.0M
Net Cash Flow$313.0M$-509.0M$-174.0M$-21.0M$71.0M
Free Cash Flow$513.0M$744.0M$71.0M$-112.0M$-83.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-10.17%
Quick Ratio0.80
Interest Coverage-5.16
Return 1Y-37.67%
Return 3Y-81.22%
Return 5Y-84.88%

Ownership

Insiders Held0.90%
Institutions Held128.19%
Institutions Float Held129.36%
Institutional HolderSharesReport Date
Blackrock Inc.10,449,1272026-03-31
FMR, LLC6,591,1522026-03-31
T. Rowe Price Investment Management, Inc.5,629,9652026-03-31
Newtyn Management, Llc4,558,4722026-03-31
Vanguard Portfolio Management LLC4,031,7682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATRC $38.72 +2.54% 80.24 $1.97B 0.00%
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%
LMAT $79.00 -25.32% 35.74 $1.81B 0.87%

About QDEL

QDEL is led by CEO Brian J. Blaser, publicly traded since 1991.

QDEL stock trades at $16.83 with a market capitalization of $1.15B. The stock is valued at a price-to-earnings (P/E) ratio of -0.65, price-to-book of 0.38, price-to-sales of 0.28. Over the past 52 weeks the stock has ranged between $9.92 and $35.58, and currently trades 52.7% below its 52-week high.

On profitability, QDEL generates a return on equity (ROE) of -58.93%, return on capital employed of -47.86%, an operating margin of -33.66%, a net profit margin of -45.57%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides